UK government to build on biotechnology success:
This article was originally published in Clinica
The UK government has set up a team of academic and business leaders to examine how the UK can maintain a competitive lead in the biotechnology industry. The science minister, Lord Sainsbury, will lead the two-month review, which will consider the growth of clusters of biotechnology companies in the UK and whether there are any barriers to their future development. The team, which includes Merlin Ventures' Dr Chris Evans, will report on the action needed to ensure biotechnology continues to flourish. The government estimates that the European market for biotech products will be worth at least £100 billion ($161 billion) by 2005.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.